本论文从制药企业的角度阐述了新产品开发的策略。
This paper mainly focuses on the strategy of new product development in the perspective of pharmaceutical manufacturers.
由于大型制药公司的重点产品许多面临专利过期，患者纷纷转向非专利药，这些公司还面临要不断开发新药品的任务。
The big pharmaceutical companies are also struggling to refill their product pipelines with new offerings as their blockbuster drugs' patents expire and patients switch to generics.
诺华赛分离技术（上海）有限公司提供整体的工艺，设备，研发服务，以及工艺和产品开发，服务于工业生物技术，医药和生物制药行业。
Novasep Asia offers complete processes, equipments, R&D services, and Process and Product Development, for the Industrial Biotech, pharmaceutical, and biopharmaceutical industries.
应用推荐